Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Dyadic International, Inc

    Client Virtual Booth

    DYADIC INTERNATIONAL, INC

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Dyadic International, Inc
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    140 Intracoastal Pointe Drive, Suite 404, Jupiter, FL 33477-5094
    Telephone
    Telephone
    561 743 8333
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.dyadic.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/dyadic-international-inc.
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes
    Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes

    https://www.globenewswire.com//news-release/2024/03/11/2843873/0/en/CORRECTION-Dyadic-Announces-Closing-of-Private-Placement-of-6-0-Million-Convertible-Notes-to-Accelerate-Near-Term-Revenue-Growth-and-Commercialization.html

    GLOBENEWSWIRE
    11 Mar 2024
    Share Share
    Dyadic to Attend Industry Events in March
    Dyadic to Attend Industry Events in March

    https://www.globenewswire.com//news-release/2024/03/01/2838801/0/en/Dyadic-to-Attend-Industry-Events-in-March.html

    GLOBENEWSWIRE
    01 Mar 2024
    Share Share
    Dyadic Advances Collaboration with IIBR Targeting Bio-Threats
    Dyadic Advances Collaboration with IIBR Targeting Bio-Threats

    https://www.globenewswire.com//news-release/2024/02/23/2834238/0/en/Dyadic-Advances-Collaboration-with-Israel-Institute-for-Biological-Research-IIBR-Targeting-Bio-Threats-and-Emerging-Disease-Solutions.html

    GLOBENEWSWIRE
    23 Feb 2024
    Share Share
    Dyadic Advances Collaboration with IIBR Targeting Bio-Threats
    Dyadic Advances Collaboration with IIBR Targeting Bio-Threats

    https://www.globenewswire.com//news-release/2024/02/21/2832746/0/en/Dyadic-Advances-Collaboration-with-Israel-Institute-for-Biological-Research-IIBR-Targeting-Bio-Threats-and-Emerging-Disease-Solutions.html

    GLOBENEWSWIRE
    21 Feb 2024
    Share Share
    Dyadic Announces R&D Agreement with Global Biopharmaceutical Company
    Dyadic Announces R&D Agreement with Global Biopharmaceutical Company

    https://www.globenewswire.com//news-release/2024/02/06/2824325/0/en/Dyadic-Announces-Research-and-Development-Collaboration-Agreement-with-Global-Biopharmaceutical-Company.html

    GLOBENEWSWIRE
    06 Feb 2024
    Share Share
    Dyadic Announces Results from iPhase 1 Trial for Fungal-Based Vaccine Candidate
    Dyadic Announces Results from iPhase 1 Trial for Fungal-Based Vaccine Candidate

    https://www.globenewswire.com//news-release/2023/11/29/2787745/0/en/Dyadic-Announces-Top-Line-Results-from-its-Successful-Phase-1-Clinical-Trial-for-a-First-in-Human-Filamentous-Fungal-Based-Vaccine-Candidate.html

    GLOBENEWSWIRE
    29 Nov 2023
    Share Share
    Dyadic to Present at Industry Events in November
    Dyadic to Present at Industry Events in November

    https://www.globenewswire.com//news-release/2023/10/30/2769223/0/en/Dyadic-to-Present-at-Industry-Events-in-November.html

    GLOBENEWSWIRE
    30 Oct 2023
    Share Share
    Dyadic Appoints Doug Pace to Its Executive Leadership Team
    Dyadic Appoints Doug Pace to Its Executive Leadership Team

    https://www.globenewswire.com//news-release/2023/10/09/2756672/0/en/Dyadic-Appoints-Doug-Pace-to-Its-Executive-Leadership-Team.html

    GLOBENEWSWIRE
    09 Oct 2023
    Share Share
    Dyadic™s C1 Platform Selected by the Vaccine and Immunotherapy Center
    Dyadic™s C1 Platform Selected by the Vaccine and Immunotherapy Center

    https://www.globenewswire.com//news-release/2023/10/05/2755390/0/en/Dyadic-s-C1-Platform-Selected-by-the-Vaccine-and-Immunotherapy-Center-VIC-at-Massachusetts-General-Hospital-as-Part-of-VIC-s-5-88-Million-Award-by-U-S-DoD-to-Develop-a-Self-Assembl.html

    GLOBENEWSWIRE
    05 Oct 2023
    Share Share
    Dyadic to Present at Industry and Investor Events in October
    Dyadic to Present at Industry and Investor Events in October

    https://www.globenewswire.com//news-release/2023/09/29/2751979/0/en/Dyadic-to-Present-at-Industry-and-Investor-Events-in-October.html

    GLOBENEWSWIRE
    29 Sep 2023
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    polpharma-m-2024-04-15

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search